Stocks in Focus

HANWHA SOLUTIONS Rises Over 8% on News of Kim Dong-kwan’s Participation in Rights Offering [Featured Stock]

Kim Kyung-eun
2026-08-04 09:20:19
[Edaily Reporter Kim Kyung-eun ] Shares of HANWHA SOLUTIONS(009830)rose in early trading on the 4th following news that Kim Dong-kwan, Senior Vice Chairman of Hanwha Group, is participating in a rights offering.



According to MP Doctor, as of 9:14 a.m. today, HANWHA SOLUTIONS is trading at 26,800 won, up 2,000 won (8.06%) from the previous trading day.

The news of Senior Vice Chairman Kim’s participation in the rights offering is seen as having boosted investor sentiment.

HANWHA SOLUTIONS announced the previous day that Senior Vice Chairman Kim acquired 23,153 common shares of HANWHA SOLUTIONS on the 31st of last month, increasing his holdings from 81,400 shares to 104,553 shares. His stake stands at 0.05%.

Hanwha, the largest shareholder of HANWHA SOLUTIONS, now holds a total of 80,357,854 shares following this rights offering. Its stake stands at 35.61%.

HANWHA SOLUTIONS had initially announced last month that it would proceed with a 2.4 trillion won rights offering. However, after the stock price subsequently fell, management expressed its commitment to responsible management.

HANWHA SOLUTIONS plans to use the funds raised to improve its financial structure by repaying debt, invest in “Solar Hub,” its integrated solar production base in the U.S., and develop next-generation solar cells.

Economy

Corporation

IT·Science

Economy

[Market In] Turning to Bank Loans Instead of Corporate Bonds… Will Even A-Rated Companies Turn Their Backs on the Bond Market Next Year?

The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
2026-11-14 16:05:05

Corporation

Rookie Baropharm and Embattled Moalife Plus Face Paradoxical Volatility as GC Genome Anchors the Market [K-Bio Pulse]

Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
2026-11-14 12:47:03

IT·Science

“The Era of 1.5 Million Robots”… The Korean Company JP Morgan Has Singled Out

A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…
2026-11-14 08:36:21